Evidence map›Paper›PMID 24891335›Full record

ArticleJournal of lipid research2014

Minimally oxidized LDL inhibits macrophage selective cholesteryl ester uptake and native LDL-induced foam cell formation.

Jason M Meyer, Ailing Ji, Lei Cai, Deneys R van der Westhuyzen

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jason M MeyerDepartment of Veterans Affairs Medical Center, Lexington, KY 40502 Departments of Internal Medicine and Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536 Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY 40536.
Ailing JiDepartment of Veterans Affairs Medical Center, Lexington, KY 40502 Departments of Internal Medicine and Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536 Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY 40536 Barnstable Brown Kentucky Diabetes and Obesity Center, University of Kentucky, Lexington, KY 40536.
Lei CaiDepartment of Veterans Affairs Medical Center, Lexington, KY 40502 Departments of Internal Medicine and Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536 Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY 40536 Barnstable Brown Kentucky Diabetes and Obesity Center, University of Kentucky, Lexington, KY 40536.
Deneys R van der WesthuyzenDepartment of Veterans Affairs Medical Center, Lexington, KY 40502 Departments of Internal Medicine and Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536 Saha Cardiovascular Research Center, University of Kentucky, Lexington, KY 40536 Barnstable Brown Kentucky Diabetes and Obesity Center, University of Kentucky, Lexington, KY 40536.
University of Kentucky · US

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J · 2012 to 2017
$13.7M
THROMBOSPONDIN1 MEDIATES MACROPHAGE INFILTRATION INTO ADIPOSE TISSUE AND PROMOTEP20RR021954 · NCRR · UNIVERSITY OF KENTUCKY · PI ECKHARDT, ERIK · 2008 to 2011
$8.3M
Mouse CoreP01HL086670 · NHLBI · UNIVERSITY OF KENTUCKY · PI DE BEER, FREDERICK C. · 2007 to 2011
$7.1M
Interdisciplinary Cardiovascular Training ProgramT32HL072743 · NHLBI · UNIVERSITY OF KENTUCKY · PI RANDALL, DAVID C · 2004 to 2013
$1.3M
Class B Scavenger Receptors and AtherosclerosisI01BX000672 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI VAN DER WESTHUYZEN, DENEYS REM · 2009 to 2013
–
BLRD VA I01 BX000672NCRR NIH HHS P20 RR021954NHLBI NIH HHS P01 HL086670NHLBI NIH HHS T32 HL072743NIGMS NIH HHS P20 GM103527
6 · The paper itself

Abstract

Scavenger receptor-mediated uptake of oxidized LDL (oxLDL) is thought to be the major mechanism of foam cell generation in atherosclerotic lesions. Recent data has indicated that native LDL is also capable of contributing to foam cell formation via low-affinity receptor-independent LDL particle pinocytosis and selective cholesteryl ester (CE) uptake. In the current investigation, Cu(2+)-induced LDL oxidation was found to inhibit macrophage selective CE uptake. Impairment of selective CE uptake was significant with LDL oxidized for as little as 30 min and correlated with oxidative fragmentation of apoB. In contrast, LDL aggregation, LDL CE oxidation, and the enhancement of scavenger receptor-mediated LDL particle uptake required at least 3 h of oxidation. Selective CE uptake did not require expression of the LDL receptor (LDL-R) and was inhibited similarly by LDL oxidation in LDL-R(-/-) versus WT macrophages. Inhibition of selective uptake was also observed when cells were pretreated or cotreated with minimally oxidized LDL, indicating a direct inhibitory effect of this oxLDL on macrophages. Consistent with the effect on LDL CE uptake, minimal LDL oxidation almost completely prevented LDL-induced foam cell formation. These data demonstrate a novel inhibitory effect of mildly oxidized LDL that may reduce foam cell formation in atherosclerosis.

Indexed as

AnimalsCholesterol EstersFoam CellsLipoproteins, LDLMiceMice, KnockoutReceptors, LDLCholesterol EstersLipoproteins, LDLoxidized low density lipoproteinReceptors, LDLLDL oxidationoxidized low density lipoproteinselective lipid uptake

Identifiers

PMID24891335
PMCPMC4109759
OpenAlexW2021160154

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.